John Gandolfo serves as Executive at BIOJECT MEDICAL TECHNOLOGIES INC, where they oversee executive responsibilities. Since joining the company, John Gandolfo has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 24, 2006 involved exercising options for 26,203 shares valued at $44.3K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 24, 2006 | BJCT | $44.3K | Conversion | 26,203 | $1.69 | Discretionary |
John Gandolfo currently holds 32,703 shares of BIOJECT MEDICAL TECHNOLOGIES INC (BJCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Gandolfo has been a net neutral trader of BJCT stock. They have purchased $0 and sold $0 worth of shares.
John Gandolfo's most recent insider trade was on Mar 24, 2006, when they sold 26,203 shares at $1.69 per share.
Get notified when new Form 4 filings are submitted